author-photo

Ayumu Hosokawa

University of Toyama

155

Papers

1000

Citations

Citation Trend

Filter By

Papers (105) Sort By

Journal Conference Others

Phase II trial of docetaxel and ramucirumab combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer (HGCSG1903).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MO5-5 Lesion-level response to immune checkpoint inhibitor in patients with advanced gastric cancer and esophageal cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of chemoselection with docetaxel, cisplatin, and 5–fluorouracil as a strategy for organ preservation in patients with resectable esophageal cancer (CROC trial).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
499P The safety and efficacy of edoxaban for the cancer-associated asymptomatic venous thromboembolism in Japanese gastrointestinal cancer patients receiving chemotherapy (ExCAVE study)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Rare resected eight cases of duodenal adenocarcinomas.

2021 International Journal of Surgery Case Reports
Show All
- Source
- Cite
- Save
Citations (0)
Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea.

2020 BMC Gastroenterology
Show All
- Source
- Cite
- Save
Citations (1)
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.

2020 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.

2020 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A phase II trial of everolimus in patients with advanced pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-containing chemotherapy (NECTOR trial)

2020 Neuroendocrinology
Show All
- Source
- Cite
- Save
Citations (9)
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial.

2019 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)